KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Change in Receivables (2016 - 2025)

Elevance Health (ELV) has disclosed Change in Receivables for 17 consecutive years, with -$756.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 491.71% to -$756.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 billion, a 269.84% increase, with the full-year FY2025 number at $2.5 billion, up 269.84% from a year prior.
  • Change in Receivables was -$756.0 million for Q4 2025 at Elevance Health, up from -$815.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $3.2 billion in Q1 2025 to a low of -$851.0 million in Q3 2024.
  • A 5-year average of $481.0 million and a median of $328.0 million in 2021 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: soared 2575.0% in 2023, then plummeted 491.71% in 2025.
  • Elevance Health's Change in Receivables stood at $387.0 million in 2021, then skyrocketed by 373.39% to $1.8 billion in 2022, then crashed by 43.5% to $1.0 billion in 2023, then tumbled by 81.35% to $193.0 million in 2024, then tumbled by 491.71% to -$756.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Change in Receivables are -$756.0 million (Q4 2025), -$815.0 million (Q3 2025), and $923.0 million (Q2 2025).